Clinical Trial Update: Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 trial evaluating the combination of clofarabine and cytarabine in children with refractory or relapsed acute myeloid leukemia or acute lymphoblastic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Clofarabine (clofarabine)

Snippet

Sponsor: Children's Oncology Group | Conditions: Leukemia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2014-02-03